nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—MTHFR—Methotrexate—esophageal cancer	0.739	1	CbGbCtD
Benazepril—ACE—thoracic aorta—esophageal cancer	0.0699	0.491	CbGeAlD
Benazepril—MTHFR—neck—esophageal cancer	0.0101	0.0708	CbGeAlD
Benazepril—MTHFR—bronchus—esophageal cancer	0.00676	0.0475	CbGeAlD
Benazepril—ACE—neck—esophageal cancer	0.00616	0.0433	CbGeAlD
Benazepril—SLC15A1—epithelium—esophageal cancer	0.00585	0.0411	CbGeAlD
Benazepril—MTHFR—digestive system—esophageal cancer	0.00522	0.0367	CbGeAlD
Benazepril—SLC15A1—digestive system—esophageal cancer	0.00445	0.0312	CbGeAlD
Benazepril—MTHFR—lung—esophageal cancer	0.00436	0.0306	CbGeAlD
Benazepril—ACE—epithelium—esophageal cancer	0.00419	0.0294	CbGeAlD
Benazepril—ACE—smooth muscle tissue—esophageal cancer	0.00404	0.0284	CbGeAlD
Benazepril—SLC15A2—bronchus—esophageal cancer	0.0036	0.0253	CbGeAlD
Benazepril—SLC15A2—trachea—esophageal cancer	0.00323	0.0227	CbGeAlD
Benazepril—ACE—digestive system—esophageal cancer	0.00319	0.0224	CbGeAlD
Benazepril—MTHFR—lymph node—esophageal cancer	0.00298	0.0209	CbGeAlD
Benazepril—ACE—lung—esophageal cancer	0.00267	0.0187	CbGeAlD
Benazepril—Serum creatinine increased—Cisplatin—esophageal cancer	0.00258	0.028	CcSEcCtD
Benazepril—SLC15A2—lung—esophageal cancer	0.00232	0.0163	CbGeAlD
Benazepril—Infection—Carboplatin—esophageal cancer	0.00192	0.0208	CcSEcCtD
Benazepril—MTHFR—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00191	0.0834	CbGpPWpGaD
Benazepril—Serum creatinine increased—Capecitabine—esophageal cancer	0.0019	0.0206	CcSEcCtD
Benazepril—ACE—lymph node—esophageal cancer	0.00182	0.0128	CbGeAlD
Benazepril—MTHFR—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.0016	0.0698	CbGpPWpGaD
Benazepril—SLC15A2—lymph node—esophageal cancer	0.00159	0.0112	CbGeAlD
Benazepril—Hyperkalaemia—Cisplatin—esophageal cancer	0.00156	0.0169	CcSEcCtD
Benazepril—Proteinuria—Capecitabine—esophageal cancer	0.00133	0.0144	CcSEcCtD
Benazepril—Protein urine present—Capecitabine—esophageal cancer	0.00131	0.0142	CcSEcCtD
Benazepril—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00128	0.0138	CcSEcCtD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—esophageal cancer	0.00121	0.0531	CbGpPWpGaD
Benazepril—Coordination abnormal—Capecitabine—esophageal cancer	0.00119	0.0129	CcSEcCtD
Benazepril—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00119	0.0129	CcSEcCtD
Benazepril—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00118	0.0128	CcSEcCtD
Benazepril—Hyponatraemia—Cisplatin—esophageal cancer	0.00116	0.0125	CcSEcCtD
Benazepril—Melaena—Capecitabine—esophageal cancer	0.00114	0.0124	CcSEcCtD
Benazepril—Face oedema—Cisplatin—esophageal cancer	0.00111	0.0121	CcSEcCtD
Benazepril—MTHFR—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00111	0.0484	CbGpPWpGaD
Benazepril—Blood creatinine increased—Cisplatin—esophageal cancer	0.00108	0.0117	CcSEcCtD
Benazepril—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00105	0.0114	CcSEcCtD
Benazepril—ACE—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.00105	0.0458	CbGpPWpGaD
Benazepril—MTHFR—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.00102	0.0447	CbGpPWpGaD
Benazepril—MTHFR—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.00102	0.0447	CbGpPWpGaD
Benazepril—Proteinuria—Methotrexate—esophageal cancer	0.000991	0.0108	CcSEcCtD
Benazepril—Protein urine present—Methotrexate—esophageal cancer	0.000977	0.0106	CcSEcCtD
Benazepril—Pancreatitis—Cisplatin—esophageal cancer	0.000976	0.0106	CcSEcCtD
Benazepril—Photosensitivity—Capecitabine—esophageal cancer	0.000967	0.0105	CcSEcCtD
Benazepril—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00094	0.0102	CcSEcCtD
Benazepril—Libido decreased—Capecitabine—esophageal cancer	0.000915	0.00994	CcSEcCtD
Benazepril—ACE—ACE Inhibitor Pathway—NOS3—esophageal cancer	0.000913	0.0399	CbGpPWpGaD
Benazepril—MTHFR—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000902	0.0394	CbGpPWpGaD
Benazepril—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000875	0.00949	CcSEcCtD
Benazepril—Arthritis—Capecitabine—esophageal cancer	0.000873	0.00948	CcSEcCtD
Benazepril—Myocardial infarction—Cisplatin—esophageal cancer	0.00087	0.00944	CcSEcCtD
Benazepril—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000866	0.0094	CcSEcCtD
Benazepril—Hyponatraemia—Capecitabine—esophageal cancer	0.000852	0.00925	CcSEcCtD
Benazepril—Melaena—Methotrexate—esophageal cancer	0.00085	0.00923	CcSEcCtD
Benazepril—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000842	0.00914	CcSEcCtD
Benazepril—Face oedema—Capecitabine—esophageal cancer	0.000819	0.00889	CcSEcCtD
Benazepril—Blood creatinine increased—Capecitabine—esophageal cancer	0.000795	0.00863	CcSEcCtD
Benazepril—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000775	0.00841	CcSEcCtD
Benazepril—Gastritis—Capecitabine—esophageal cancer	0.000751	0.00815	CcSEcCtD
Benazepril—Tinnitus—Cisplatin—esophageal cancer	0.000743	0.00806	CcSEcCtD
Benazepril—Flushing—Cisplatin—esophageal cancer	0.000739	0.00802	CcSEcCtD
Benazepril—Influenza—Capecitabine—esophageal cancer	0.000734	0.00796	CcSEcCtD
Benazepril—Asthma—Capecitabine—esophageal cancer	0.000734	0.00796	CcSEcCtD
Benazepril—Photosensitivity—Methotrexate—esophageal cancer	0.00072	0.00781	CcSEcCtD
Benazepril—Angina pectoris—Capecitabine—esophageal cancer	0.000715	0.00776	CcSEcCtD
Benazepril—Arrhythmia—Cisplatin—esophageal cancer	0.000712	0.00772	CcSEcCtD
Benazepril—Bronchitis—Capecitabine—esophageal cancer	0.000706	0.00766	CcSEcCtD
Benazepril—Alopecia—Cisplatin—esophageal cancer	0.000704	0.00764	CcSEcCtD
Benazepril—Neutropenia—Capecitabine—esophageal cancer	0.000686	0.00745	CcSEcCtD
Benazepril—Flatulence—Cisplatin—esophageal cancer	0.000683	0.00742	CcSEcCtD
Benazepril—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00067	0.00727	CcSEcCtD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—esophageal cancer	0.000665	0.0291	CbGpPWpGaD
Benazepril—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000653	0.00709	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000648	0.00704	CcSEcCtD
Benazepril—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000645	0.007	CcSEcCtD
Benazepril—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000645	0.007	CcSEcCtD
Benazepril—Myocardial infarction—Capecitabine—esophageal cancer	0.000641	0.00696	CcSEcCtD
Benazepril—Urinary tract infection—Capecitabine—esophageal cancer	0.000636	0.0069	CcSEcCtD
Benazepril—Leukopenia—Cisplatin—esophageal cancer	0.000621	0.00674	CcSEcCtD
Benazepril—Cilazapril—ABCB1—esophageal cancer	0.000614	0.18	CrCbGaD
Benazepril—Lisinopril—ABCB1—esophageal cancer	0.000614	0.18	CrCbGaD
Benazepril—Agranulocytosis—Capecitabine—esophageal cancer	0.00061	0.00663	CcSEcCtD
Benazepril—Myalgia—Cisplatin—esophageal cancer	0.00059	0.00641	CcSEcCtD
Benazepril—Rhinitis—Capecitabine—esophageal cancer	0.000589	0.00639	CcSEcCtD
Benazepril—Anxiety—Cisplatin—esophageal cancer	0.000588	0.00639	CcSEcCtD
Benazepril—Hepatitis—Capecitabine—esophageal cancer	0.000587	0.00637	CcSEcCtD
Benazepril—Pharyngitis—Capecitabine—esophageal cancer	0.000583	0.00633	CcSEcCtD
Benazepril—Oedema peripheral—Capecitabine—esophageal cancer	0.000578	0.00628	CcSEcCtD
Benazepril—Oedema—Cisplatin—esophageal cancer	0.000566	0.00614	CcSEcCtD
Benazepril—Anaphylactic shock—Cisplatin—esophageal cancer	0.000566	0.00614	CcSEcCtD
Benazepril—Infection—Cisplatin—esophageal cancer	0.000562	0.0061	CcSEcCtD
Benazepril—ACE—Peptide hormone metabolism—GHRL—esophageal cancer	0.000559	0.0245	CbGpPWpGaD
Benazepril—Erythema multiforme—Capecitabine—esophageal cancer	0.000555	0.00603	CcSEcCtD
Benazepril—Thrombocytopenia—Cisplatin—esophageal cancer	0.000554	0.00601	CcSEcCtD
Benazepril—Tinnitus—Capecitabine—esophageal cancer	0.000547	0.00594	CcSEcCtD
Benazepril—Hyperhidrosis—Cisplatin—esophageal cancer	0.000547	0.00594	CcSEcCtD
Benazepril—Asthma—Methotrexate—esophageal cancer	0.000546	0.00593	CcSEcCtD
Benazepril—Flushing—Capecitabine—esophageal cancer	0.000545	0.00592	CcSEcCtD
Benazepril—Eosinophilia—Methotrexate—esophageal cancer	0.000541	0.00587	CcSEcCtD
Benazepril—Pancreatitis—Methotrexate—esophageal cancer	0.000535	0.00581	CcSEcCtD
Benazepril—Hypotension—Cisplatin—esophageal cancer	0.000529	0.00574	CcSEcCtD
Benazepril—Arrhythmia—Capecitabine—esophageal cancer	0.000525	0.00569	CcSEcCtD
Benazepril—Alopecia—Capecitabine—esophageal cancer	0.000519	0.00563	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000516	0.0056	CcSEcCtD
Benazepril—Neutropenia—Methotrexate—esophageal cancer	0.000511	0.00554	CcSEcCtD
Benazepril—Paraesthesia—Cisplatin—esophageal cancer	0.000508	0.00552	CcSEcCtD
Benazepril—MTHFR—Vitamin B12 Metabolism—SOD2—esophageal cancer	0.000506	0.0221	CbGpPWpGaD
Benazepril—Dyspnoea—Cisplatin—esophageal cancer	0.000505	0.00548	CcSEcCtD
Benazepril—Flatulence—Capecitabine—esophageal cancer	0.000504	0.00547	CcSEcCtD
Benazepril—Desipramine—CYP2A6—esophageal cancer	0.000504	0.148	CrCbGaD
Benazepril—Erectile dysfunction—Methotrexate—esophageal cancer	0.000503	0.00546	CcSEcCtD
Benazepril—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000498	0.00541	CcSEcCtD
Benazepril—Back pain—Capecitabine—esophageal cancer	0.000494	0.00537	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000483	0.00524	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000479	0.0209	CbGpPWpGaD
Benazepril—Sweating—Methotrexate—esophageal cancer	0.000467	0.00507	CcSEcCtD
Benazepril—Vertigo—Capecitabine—esophageal cancer	0.000459	0.00498	CcSEcCtD
Benazepril—Syncope—Capecitabine—esophageal cancer	0.000458	0.00498	CcSEcCtD
Benazepril—Leukopenia—Capecitabine—esophageal cancer	0.000458	0.00497	CcSEcCtD
Benazepril—Agranulocytosis—Methotrexate—esophageal cancer	0.000454	0.00493	CcSEcCtD
Benazepril—Palpitations—Capecitabine—esophageal cancer	0.000452	0.0049	CcSEcCtD
Benazepril—Enalapril—ABCB1—esophageal cancer	0.00045	0.132	CrCbGaD
Benazepril—Loss of consciousness—Capecitabine—esophageal cancer	0.000449	0.00488	CcSEcCtD
Benazepril—Cough—Capecitabine—esophageal cancer	0.000446	0.00484	CcSEcCtD
Benazepril—Hepatitis—Methotrexate—esophageal cancer	0.000437	0.00474	CcSEcCtD
Benazepril—Arthralgia—Capecitabine—esophageal cancer	0.000435	0.00472	CcSEcCtD
Benazepril—Chest pain—Capecitabine—esophageal cancer	0.000435	0.00472	CcSEcCtD
Benazepril—Myalgia—Capecitabine—esophageal cancer	0.000435	0.00472	CcSEcCtD
Benazepril—Pharyngitis—Methotrexate—esophageal cancer	0.000434	0.00471	CcSEcCtD
Benazepril—Anxiety—Capecitabine—esophageal cancer	0.000434	0.00471	CcSEcCtD
Benazepril—Oedema—Capecitabine—esophageal cancer	0.000417	0.00453	CcSEcCtD
Benazepril—Hypersensitivity—Cisplatin—esophageal cancer	0.000417	0.00453	CcSEcCtD
Benazepril—Infection—Capecitabine—esophageal cancer	0.000414	0.0045	CcSEcCtD
Benazepril—Erythema multiforme—Methotrexate—esophageal cancer	0.000413	0.00449	CcSEcCtD
Benazepril—MTHFR—Folate Metabolism—SOD2—esophageal cancer	0.000411	0.018	CbGpPWpGaD
Benazepril—Shock—Capecitabine—esophageal cancer	0.00041	0.00445	CcSEcCtD
Benazepril—Thrombocytopenia—Capecitabine—esophageal cancer	0.000408	0.00443	CcSEcCtD
Benazepril—Tinnitus—Methotrexate—esophageal cancer	0.000408	0.00442	CcSEcCtD
Benazepril—Asthenia—Cisplatin—esophageal cancer	0.000406	0.00441	CcSEcCtD
Benazepril—Hyperhidrosis—Capecitabine—esophageal cancer	0.000403	0.00438	CcSEcCtD
Benazepril—Hypotension—Capecitabine—esophageal cancer	0.00039	0.00423	CcSEcCtD
Benazepril—Diarrhoea—Cisplatin—esophageal cancer	0.000387	0.0042	CcSEcCtD
Benazepril—Alopecia—Methotrexate—esophageal cancer	0.000386	0.00419	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00038	0.00413	CcSEcCtD
Benazepril—Insomnia—Capecitabine—esophageal cancer	0.000377	0.0041	CcSEcCtD
Benazepril—Paraesthesia—Capecitabine—esophageal cancer	0.000375	0.00407	CcSEcCtD
Benazepril—Dyspnoea—Capecitabine—esophageal cancer	0.000372	0.00404	CcSEcCtD
Benazepril—Back pain—Methotrexate—esophageal cancer	0.000368	0.004	CcSEcCtD
Benazepril—Dyspepsia—Capecitabine—esophageal cancer	0.000367	0.00399	CcSEcCtD
Benazepril—Propafenone—ABCB1—esophageal cancer	0.000362	0.106	CrCbGaD
Benazepril—Vomiting—Cisplatin—esophageal cancer	0.00036	0.00391	CcSEcCtD
Benazepril—Fatigue—Capecitabine—esophageal cancer	0.00036	0.0039	CcSEcCtD
Benazepril—Rash—Cisplatin—esophageal cancer	0.000357	0.00387	CcSEcCtD
Benazepril—Constipation—Capecitabine—esophageal cancer	0.000357	0.00387	CcSEcCtD
Benazepril—Dermatitis—Cisplatin—esophageal cancer	0.000357	0.00387	CcSEcCtD
Benazepril—Vertigo—Methotrexate—esophageal cancer	0.000342	0.00371	CcSEcCtD
Benazepril—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000341	0.0037	CcSEcCtD
Benazepril—Leukopenia—Methotrexate—esophageal cancer	0.000341	0.0037	CcSEcCtD
Benazepril—Nausea—Cisplatin—esophageal cancer	0.000336	0.00365	CcSEcCtD
Benazepril—Cough—Methotrexate—esophageal cancer	0.000332	0.0036	CcSEcCtD
Benazepril—Abdominal pain—Capecitabine—esophageal cancer	0.00033	0.00358	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000327	0.0143	CbGpPWpGaD
Benazepril—Chest pain—Methotrexate—esophageal cancer	0.000324	0.00352	CcSEcCtD
Benazepril—Myalgia—Methotrexate—esophageal cancer	0.000324	0.00352	CcSEcCtD
Benazepril—Arthralgia—Methotrexate—esophageal cancer	0.000324	0.00352	CcSEcCtD
Benazepril—Anaphylactic shock—Methotrexate—esophageal cancer	0.000311	0.00337	CcSEcCtD
Benazepril—Infection—Methotrexate—esophageal cancer	0.000309	0.00335	CcSEcCtD
Benazepril—Hypersensitivity—Capecitabine—esophageal cancer	0.000307	0.00334	CcSEcCtD
Benazepril—Thrombocytopenia—Methotrexate—esophageal cancer	0.000304	0.0033	CcSEcCtD
Benazepril—Hyperhidrosis—Methotrexate—esophageal cancer	0.0003	0.00326	CcSEcCtD
Benazepril—Asthenia—Capecitabine—esophageal cancer	0.000299	0.00325	CcSEcCtD
Benazepril—Fentanyl—ABCB1—esophageal cancer	0.000296	0.0872	CrCbGaD
Benazepril—Pruritus—Capecitabine—esophageal cancer	0.000295	0.0032	CcSEcCtD
Benazepril—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000292	0.0128	CbGpPWpGaD
Benazepril—Hypotension—Methotrexate—esophageal cancer	0.00029	0.00315	CcSEcCtD
Benazepril—Diarrhoea—Capecitabine—esophageal cancer	0.000285	0.0031	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000283	0.00307	CcSEcCtD
Benazepril—Insomnia—Methotrexate—esophageal cancer	0.000281	0.00305	CcSEcCtD
Benazepril—Paraesthesia—Methotrexate—esophageal cancer	0.000279	0.00303	CcSEcCtD
Benazepril—Dyspnoea—Methotrexate—esophageal cancer	0.000277	0.00301	CcSEcCtD
Benazepril—Somnolence—Methotrexate—esophageal cancer	0.000276	0.003	CcSEcCtD
Benazepril—Dizziness—Capecitabine—esophageal cancer	0.000276	0.00299	CcSEcCtD
Benazepril—Dyspepsia—Methotrexate—esophageal cancer	0.000273	0.00297	CcSEcCtD
Benazepril—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000271	0.0119	CbGpPWpGaD
Benazepril—Fatigue—Methotrexate—esophageal cancer	0.000268	0.00291	CcSEcCtD
Benazepril—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000267	0.0117	CbGpPWpGaD
Benazepril—Vomiting—Capecitabine—esophageal cancer	0.000265	0.00288	CcSEcCtD
Benazepril—Rash—Capecitabine—esophageal cancer	0.000263	0.00286	CcSEcCtD
Benazepril—Dermatitis—Capecitabine—esophageal cancer	0.000263	0.00285	CcSEcCtD
Benazepril—Headache—Capecitabine—esophageal cancer	0.000261	0.00284	CcSEcCtD
Benazepril—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000254	0.00276	CcSEcCtD
Benazepril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000248	0.0108	CbGpPWpGaD
Benazepril—Nausea—Capecitabine—esophageal cancer	0.000248	0.00269	CcSEcCtD
Benazepril—Abdominal pain—Methotrexate—esophageal cancer	0.000246	0.00266	CcSEcCtD
Benazepril—MTHFR—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000239	0.0105	CbGpPWpGaD
Benazepril—Hypersensitivity—Methotrexate—esophageal cancer	0.000229	0.00248	CcSEcCtD
Benazepril—Asthenia—Methotrexate—esophageal cancer	0.000223	0.00242	CcSEcCtD
Benazepril—Pruritus—Methotrexate—esophageal cancer	0.00022	0.00238	CcSEcCtD
Benazepril—Trimipramine—ABCB1—esophageal cancer	0.000214	0.0631	CrCbGaD
Benazepril—Diarrhoea—Methotrexate—esophageal cancer	0.000212	0.00231	CcSEcCtD
Benazepril—ACE—Metabolism of proteins—XBP1—esophageal cancer	0.000206	0.00902	CbGpPWpGaD
Benazepril—Dizziness—Methotrexate—esophageal cancer	0.000205	0.00223	CcSEcCtD
Benazepril—ACE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000198	0.00865	CbGpPWpGaD
Benazepril—Vomiting—Methotrexate—esophageal cancer	0.000197	0.00214	CcSEcCtD
Benazepril—Rash—Methotrexate—esophageal cancer	0.000196	0.00213	CcSEcCtD
Benazepril—Dermatitis—Methotrexate—esophageal cancer	0.000196	0.00212	CcSEcCtD
Benazepril—Headache—Methotrexate—esophageal cancer	0.000195	0.00211	CcSEcCtD
Benazepril—Desipramine—ABCB1—esophageal cancer	0.000187	0.0551	CrCbGaD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	0.000185	0.0081	CbGpPWpGaD
Benazepril—Nausea—Methotrexate—esophageal cancer	0.000184	0.002	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000184	0.00803	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000178	0.00779	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000167	0.00728	CbGpPWpGaD
Benazepril—Imipramine—ABCB1—esophageal cancer	0.000159	0.0468	CrCbGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000157	0.00685	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000155	0.00676	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000148	0.00649	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000145	0.00636	CbGpPWpGaD
Benazepril—MTHFR—Disease—SLC52A3—esophageal cancer	0.000144	0.00628	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000142	0.00619	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000138	0.00603	CbGpPWpGaD
Benazepril—MTHFR—Folate Metabolism—TP53—esophageal cancer	0.000138	0.00601	CbGpPWpGaD
Benazepril—MTHFR—Disease—KMT2D—esophageal cancer	0.000137	0.00599	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000136	0.00594	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000136	0.00594	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000131	0.00575	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000126	0.00551	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000126	0.00551	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—ACTB—esophageal cancer	0.000123	0.00536	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—BLVRB—esophageal cancer	0.00012	0.00526	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—SLC52A3—esophageal cancer	0.00012	0.00526	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—HSPA5—esophageal cancer	0.000111	0.00485	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—CALR—esophageal cancer	0.000107	0.0047	CbGpPWpGaD
Benazepril—MTHFR—Disease—FKBP1A—esophageal cancer	0.000106	0.00465	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—GHRL—esophageal cancer	0.000106	0.00462	CbGpPWpGaD
Benazepril—MTHFR—Disease—WIF1—esophageal cancer	0.000104	0.00454	CbGpPWpGaD
Benazepril—MTHFR—Disease—DOCK2—esophageal cancer	0.000104	0.00454	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—FBXW7—esophageal cancer	0.000104	0.00454	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000103	0.0045	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—SLC10A2—esophageal cancer	0.000102	0.00447	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CA1—esophageal cancer	0.000102	0.00447	CbGpPWpGaD
Benazepril—MTHFR—Disease—CSNK1A1—esophageal cancer	9.59e-05	0.00419	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.55e-05	0.00418	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CA2—esophageal cancer	9.36e-05	0.00409	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.34e-05	0.00408	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PLCE1—esophageal cancer	8.7e-05	0.0038	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ADH7—esophageal cancer	8.7e-05	0.0038	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.67e-05	0.00379	CbGpPWpGaD
Benazepril—MTHFR—Disease—ELMO1—esophageal cancer	8.06e-05	0.00352	CbGpPWpGaD
Benazepril—MTHFR—Disease—GSTO1—esophageal cancer	7.87e-05	0.00344	CbGpPWpGaD
Benazepril—MTHFR—Disease—TPI1—esophageal cancer	7.87e-05	0.00344	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ADH1B—esophageal cancer	7.63e-05	0.00334	CbGpPWpGaD
Benazepril—MTHFR—Disease—ALDOB—esophageal cancer	7.55e-05	0.0033	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—TYMP—esophageal cancer	7.29e-05	0.00319	CbGpPWpGaD
Benazepril—MTHFR—Disease—HIST1H2BM—esophageal cancer	7.27e-05	0.00318	CbGpPWpGaD
Benazepril—MTHFR—Disease—GAPDH—esophageal cancer	7.27e-05	0.00318	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CYP26A1—esophageal cancer	7.09e-05	0.0031	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ALOX15—esophageal cancer	6.91e-05	0.00302	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—TPI1—esophageal cancer	6.59e-05	0.00288	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GSTO1—esophageal cancer	6.59e-05	0.00288	CbGpPWpGaD
Benazepril—MTHFR—Disease—XIAP—esophageal cancer	6.42e-05	0.00281	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ALDOB—esophageal cancer	6.32e-05	0.00276	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GAPDH—esophageal cancer	6.09e-05	0.00266	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CRABP1—esophageal cancer	6.03e-05	0.00264	CbGpPWpGaD
Benazepril—MTHFR—Disease—B2M—esophageal cancer	5.97e-05	0.00261	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GNG7—esophageal cancer	5.74e-05	0.00251	CbGpPWpGaD
Benazepril—MTHFR—Disease—ENO1—esophageal cancer	5.72e-05	0.0025	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.69e-05	0.00249	CbGpPWpGaD
Benazepril—MTHFR—Disease—PSME2—esophageal cancer	5.64e-05	0.00247	CbGpPWpGaD
Benazepril—MTHFR—Disease—PSME1—esophageal cancer	5.64e-05	0.00247	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.46e-05	0.00239	CbGpPWpGaD
Benazepril—MTHFR—Disease—CALR—esophageal cancer	5.41e-05	0.00237	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ALDH2—esophageal cancer	5.38e-05	0.00235	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.28e-05	0.00231	CbGpPWpGaD
Benazepril—MTHFR—Disease—FBXW7—esophageal cancer	5.23e-05	0.00229	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GSTT1—esophageal cancer	5.11e-05	0.00224	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.07e-05	0.00222	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CYP2A6—esophageal cancer	5.05e-05	0.00221	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ENO1—esophageal cancer	4.79e-05	0.0021	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PTGS1—esophageal cancer	4.79e-05	0.0021	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PSME2—esophageal cancer	4.72e-05	0.00206	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PSME1—esophageal cancer	4.72e-05	0.00206	CbGpPWpGaD
Benazepril—MTHFR—Disease—TGFBR2—esophageal cancer	4.23e-05	0.00185	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CYP1B1—esophageal cancer	4.07e-05	0.00178	CbGpPWpGaD
Benazepril—MTHFR—Disease—SMAD4—esophageal cancer	4.01e-05	0.00175	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CYP19A1—esophageal cancer	3.83e-05	0.00167	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.65e-05	0.0016	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—HMOX1—esophageal cancer	3.5e-05	0.00153	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.39e-05	0.00148	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ABCB1—esophageal cancer	3.35e-05	0.00147	CbGpPWpGaD
Benazepril—MTHFR—Disease—HIF1A—esophageal cancer	3.28e-05	0.00143	CbGpPWpGaD
Benazepril—MTHFR—Disease—NOS2—esophageal cancer	2.98e-05	0.0013	CbGpPWpGaD
Benazepril—MTHFR—Disease—NOTCH1—esophageal cancer	2.95e-05	0.00129	CbGpPWpGaD
Benazepril—MTHFR—Disease—CREBBP—esophageal cancer	2.68e-05	0.00117	CbGpPWpGaD
Benazepril—MTHFR—Disease—NOS3—esophageal cancer	2.4e-05	0.00105	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CREBBP—esophageal cancer	2.24e-05	0.00098	CbGpPWpGaD
Benazepril—MTHFR—Disease—ERBB2—esophageal cancer	2.24e-05	0.00098	CbGpPWpGaD
Benazepril—MTHFR—Disease—PTGS2—esophageal cancer	2.19e-05	0.000959	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—NOS3—esophageal cancer	2.01e-05	0.000878	CbGpPWpGaD
Benazepril—MTHFR—Disease—CDKN1A—esophageal cancer	1.92e-05	0.000838	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PTGS2—esophageal cancer	1.84e-05	0.000803	CbGpPWpGaD
Benazepril—MTHFR—Disease—EP300—esophageal cancer	1.82e-05	0.000797	CbGpPWpGaD
Benazepril—MTHFR—Disease—MYC—esophageal cancer	1.59e-05	0.000695	CbGpPWpGaD
Benazepril—MTHFR—Disease—EGFR—esophageal cancer	1.55e-05	0.00068	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—EP300—esophageal cancer	1.53e-05	0.000668	CbGpPWpGaD
Benazepril—MTHFR—Disease—PIK3CA—esophageal cancer	1.35e-05	0.00059	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PIK3CA—esophageal cancer	1.13e-05	0.000494	CbGpPWpGaD
